✦ LIBER ✦

Sequence dependence of hematologic toxicity using carboplatin and topotecan for primary therapy of advanced epithelial ovarian cancer: A phase I study of the Gynecologic Oncology Group

✍ Scribed by Michael A. Bookman; D. Scott McMeekin; Paula M. Fracasso

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of paclitaxel, topotecan

✍ Deborah K. Armstrong; Michael A. Bookman; William McGuire; Robert E. Bristow; Je 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Phase I feasibility trial of carboplatin

✍ Katherine Y Look; Michael A Bookman; Jessie Schol; Thomas J Herzog; Thomas Rocer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

A phase I study of concurrent weekly top

✍ Peter G. Rose; Michael W. Sill; D. Scott McMeekin; Amina Ahmed; Ritu Salani; S. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Low-dose abdominal radiation as a doceta

✍ Charles A. Kunos; Michael W. Sill; Thomas E. Buekers; Joan L. Walker; Jeanne M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Independent radiologic review of the Gyn

✍ Burger, Robert. A.; Brady, Mark F.; Rhee, Joon; Sovak, Mika A.; Kong, George; Ng 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 393 KB

Paclitaxel poliglumex and carboplatin as

✍ Mark A. Morgan; Kathleen M. Darcy; Peter G. Rose; Koen DeGeest; Michael A. Bookm 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 164 KB